This most up-to-date twist within the Lykos Therapeutics saga threatens a major overhaul of the corporate’s approach and path, with Musk ally and billionaire Trader Antonio Gracias appearing to desire to just take the company back again towards its nonprofit drug enhancement roots and a more Doblinite philosophy.One of many essential capabilities